Tower Research Capital (TRC)’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$241K Sell
2,898
-397
-12% -$21.6K 0.01% 1550
2026
Q1
$127K Buy
3,295
+3,271
+13,629% +$136K ﹤0.01% 1992
2025
Q4
$1.11K Sell
24
-431
-95% -$20.8K ﹤0.01% 4758
2025
Q3
$22.3K Buy
455
+354
+350% +$18.5K ﹤0.01% 3219
2025
Q2
$5.23K Buy
+101
New +$4.08K ﹤0.01% 4212

Other funds holding HNGE

Tower Research Capital (TRC)'s HNGE Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Hinge Health (HNGE) stake by 12% in Q2 2026, selling an estimated $21.6K and leaving 2,898 shares worth $241K. The position accounts for 0.01% of the portfolio, ranked #1550.

Tower Research Capital (TRC) first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. 276 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Tower Research Capital (TRC) held 2,898 shares of Hinge Health worth $241K as of Q2 2026.
  • Tower Research Capital (TRC) sold 397 Hinge Health shares in Q2 2026, an estimated $21.6K.
  • Hinge Health made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1550 holding.
  • Tower Research Capital (TRC) first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
  • 276 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.